摘要
背景:沉默的两个或两个以上的互补信号通路可导致细胞死亡,而任何单一的基因功能的丧失并没有显示出严重的表型,这种相互作用称为“合成致死”。如今,合成性致死已成为广泛使用的抗癌策略。 方法:我们回顾了2016年以前抗肿瘤治疗中的合成致死相互作用。 结论:合成致死是行之有效的抗癌策略,更多的合成致命的相互作用已被转化成临床癌症的治疗。
关键词: 合成致死,靶向治疗,PARP抑制剂,耐药性,癌症治疗、信号转导通路。
图形摘要
Current Cancer Drug Targets
Title:Synthetic Lethal Interactions in Cancer Therapy
Volume: 17 Issue: 4
关键词: 合成致死,靶向治疗,PARP抑制剂,耐药性,癌症治疗、信号转导通路。
摘要: Background: Silencing of two or more complementary signaling pathways can lead to cell death, while loss of any single genetic function does not show a severe phnotype, this kind of inter action is coined as “synthetic lethality”. Nowadays, synthetic lethality has become a widely used anti-cancer strategy.
Method: We reviewed the synthetic lethal interactions exploited in anticancer therapies before 2016. Conclusion: Synthetic lethality is a well proved anticancer strategy and more synthetic lethal interactions is being translated into clinical cancer therapies.Export Options
About this article
Cite this article as:
Synthetic Lethal Interactions in Cancer Therapy, Current Cancer Drug Targets 2017; 17 (4) . https://dx.doi.org/10.2174/1568009616666160426122736
DOI https://dx.doi.org/10.2174/1568009616666160426122736 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Applications of High Content Screening in Life Science Research
Combinatorial Chemistry & High Throughput Screening Editorial
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry An Update on Extemporaneous Preparation of Radiopharmaceuticals Using Freeze-Dried Cold Kits
Mini-Reviews in Medicinal Chemistry Microdissection and the Study of Cancer Pathways
Current Molecular Medicine Gene Therapy in Cerebrovascular Diseases
Current Gene Therapy Amino Acid Degrading Enzymes and their Application in Cancer Therapy
Current Medicinal Chemistry Non-Genotoxic p53-Activators and their Significance as Antitumor Therapy of Future
Current Medicinal Chemistry Production and Application of Copper Radiopharmaceuticals
Current Radiopharmaceuticals Mechanisms of Tumor Cell Necrosis
Current Pharmaceutical Design Metal Based Frameworks for Drug Delivery Systems
Current Topics in Medicinal Chemistry High-Risk Neuroblastoma: Poor Outcomes Despite Aggressive Multimodal Therapy
Current Cancer Therapy Reviews Multidrug Transporters as Drug Targets
Current Drug Targets Illuminating microRNA Transcription from the Epigenome
Current Genomics Anticancer Properties of Amino Acid and Peptide Derivatives of Mycophenolic Acid
Anti-Cancer Agents in Medicinal Chemistry Signaling Mechanism(S) of Reactive Oxygen Species in Epithelial-Mesenchymal Transition Reminiscent of Cancer Stem Cells in Tumor Progression
Current Stem Cell Research & Therapy PP2A and Alzheimer Disease
Current Alzheimer Research LRRC4 Inhibits Glioma Cell Growth and Invasion Through a miR-185- Dependent Pathway
Current Cancer Drug Targets Class II Phosphoinositide 3-Kinases as Potential Novel Drug Targets
Current Signal Transduction Therapy The Stress Rheostat: An Interplay Between the Unfolded Protein Response (UPR) and Autophagy in Neurodegeneration
Current Molecular Medicine The Complement Cascade: New Avenues in Stroke Therapy
Current Vascular Pharmacology